Table 1 Demographic and Clinical Data of the Patients
From: Impact of Asthma Education Meeting on Asthma Control Level Assessed by Asthma Control Test
N (%) | All Patients (n:44) |
|---|---|
Age* | 41.2 ± 13.8 |
Female/male | 33 (75)/11 (25) |
Education level; (year)* | 7 ± 3.5 |
Low educated | 25 (56.8) |
Moderate-high educated | 19 (43.2) |
Current smokers | 7 (15.9) |
Duration of asthma (year)* | 8.9 ± 3.5 |
Severity of asthma | |
Mild persistent | 19 (43.2) |
Moderate-severe persistent | 25 (56.8) |
Asthma exacerbation frequency (/yr)* | 2.1 ± 1.9 |
Hospitalisation frequency (/yr)* | 0.6 ± 1.0 |
Asthma comorbidity | |
Obesity | 23 (52.2) |
Drug allergy | 5 (11.4) |
Gastro esophageal reflux | 5 (11.4) |
Sinusitis | 26 (59.1) |
Rhinitis | 29 (54.5) |
Atopy | 14 (31.8) |
FEV1%* | 84 ± 14.5 |
Asthma management | |
LTRA | 23 (52.2) |
Inhaled steroid | 40 (91) |
Nasal steroid | 18 (40.9) |
Long-short acting β2 agonist | 35 (79.5) |
Specific immunotherapy | 3 (6.8) |
Total IgE (kU/l)* | 350 ± 317 |